A plant protein signal sequence improved humoral immune response to HPV prophylactic and therapeutic DNA vaccines

References

• Vici P, Mariani L, Pizzuti L, Sergi D, Di Lauro L, Vizza E, Tomao F, Tomao S, Mancini E, Vincenzoni C, et al. Emerging biological treatments for uterine cervical carcinoma. J Cancer 2014; 5:86-97; PMID:24494026; http://dx.doi.org/10.7150/jca.7963
   PubMed Web of Science ®Google Scholar
• Mariani L, Venuti A. HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future. J Transl Med 2010; 8:105; PMID:20979636; http://dx.doi.org/10.1186/1479-5876-8-105
   PubMed Web of Science ®Google Scholar
• Tyler M, Tunban E, Chackerian B. Second-generation prophylactic HPV vaccines: successes and challenges. Expert Rev Vaccines 2014; 13:247-55; PMID:24350614; http://dx.doi.org/10.1586/14760584.2014.865523
   PubMed Web of Science ®Google Scholar
• Whang DW, Zhihai L, Jieqiong X, Junqi W, Li Z, Yajing L, Fei F, Lu X, Minxi W, Zhibo K, et al. Identification of broad-genotype HPV L2 neutralization site for pan-HPV vaccine development by a cross-neutralizing antibody. PLoS One 2015; 10:1-18
   Web of Science ®Google Scholar
• Ghambira R, Karanam B, Jagu S, Roberts JN, Buck CB, Bossis I, Alphs H, Culp T, Christensen ND, Roden RB. A protective and broadly cross-neutralizing epitope of human papillomavirus L2. J Virol 2007; 81:13927-31; PMID:17928339; http://dx.doi.org/10.1128/JVI.00936-07
   PubMed Web of Science ®Google Scholar
• Franconi R, Massa S, Illiano E, Muller A, Cirilli A, Accardi L, Di Bonito P, Giorgi C, Venuti A. International J Immunopathol Pharmacol 2006; 19:785-95
   Google Scholar
• Massa S, Simeone P, Muller A, Benvenuto E, Venuti A, Franconi R. Antitumor activity of DNA vaccines based on the human papillomavirus-16 E7 protein genetically fused to a plant virus coat protein. Hum Gene Ther 2008; 19:354-64; PMID:18439124; http://dx.doi.org/10.1089/hum.2007.122
   PubMed Web of Science ®Google Scholar
• Massa S, Paolini F, Spanò L, Franconi R, Venuti A. Mutants of plant genes for developing cancer vaccines. Human Vaccines 2011; 7:147-55; PMID:21266841; http://dx.doi.org/10.4161/hv.7.0.14577
   PubMed Web of Science ®Google Scholar
• Franconi R, Demurtas OC, Massa S. Plant-derived vaccines and other therapeutics produced in contained systems. Expert Rev Vaccines 2010; 9:877-92; PMID:20673011; http://dx.doi.org/10.1586/erv.10.91
   PubMed Web of Science ®Google Scholar
• Massa S, Franconi R, Brandi R, Muller A, Mett V, Yusibov V, Venuti A. Anti-cancer activity of plantproduced HPV16 E7 vaccine. Vaccine 2007; 25:3018-21; PMID:17280752; http://dx.doi.org/10.1016/j.vaccine.2007.01.018
   PubMed Web of Science ®Google Scholar
• Venuti A, Massa S, Mett V, Vedova LD, Paolini F, Franconi R, Yusibov V. An E7-based therapeutic vaccine protects mice against HPV16 associated cancer. Vaccine 2009; 27:3395-97; PMID:19200826; http://dx.doi.org/10.1016/j.vaccine.2009.01.068
   PubMed Web of Science ®Google Scholar
• Schillberg S, Zimmermann S, Voss A, Fischer R. Apoplastic and cytosolic expression of full-size antibodies and antibody fragments in Nicotiana tabacum. Transgenic Res 1999; 8:255-63; PMID:10621973; http://dx.doi.org/10.1023/A:1008937011213
   PubMed Web of Science ®Google Scholar
• Vici P, Pizzuti L, Mariani L, Zampa G, Santini D, Di Lauro L, Gamucci T, Natoli C, Marchetti P, Barba M, et al. Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies. Expert Rev Vaccines 2016; 9:1-10
   Google Scholar
• Kutzler MA, Weiner DB. DNA vaccines: ready for prime time? Nat Rev Genet 2008; 9:776-88; PMID:18781156; http://dx.doi.org/10.1038/nrg2432
   PubMed Web of Science ®Google Scholar
• Hallengärd D, Haller BK, Maltais A-K, Gelius E, Nihlmark K, Wahren B, Bråve1 A. Comparison of plasmid vaccine immunization schedules using intradermal in vivo electroporation. Clin Vaccine Immunol 2011; 18:1577-81; http://dx.doi.org/10.1128/CVI.05045-11
   PubMed Web of Science ®Google Scholar
• Low L, Mander A, McCann K, Dearnaley D, Tjelle T, Mathiesen I, Stevenson F, Ottensmeier CH. DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer. Hum Gene Ther 2009; 20:1269-78; PMID:19619001; http://dx.doi.org/10.1089/hum.2009.067
   PubMed Web of Science ®Google Scholar
• Vasan S, Hurley A, Schlesinger SJ, Hannaman D, Gardiner DF, Dugin DP, Boente-Carrera M, Vittorino R, Caskey M, Andersen J, et al. In vivo electroporation enhances the immunogenicity of a HIV-1 DNA vaccine candidate in healthy volunteers. PLoS One 2011; 6:e19252; PMID:21603651; http://dx.doi.org/10.1371/journal.pone.0019252
   PubMed Web of Science ®Google Scholar
• Güler-Gane G, Kidd S, Sridharan S, Vaughan TJ, Wilkinson TCI, Tigue NJ. Overcoming the refractory expression of secreted recombinant proteins in mammalian cells through modification of the signal peptide and adjacent amino acids. PLoS One 2016; 11:e0155340; PMID:27195765; http://dx.doi.org/10.1371/journal.pone.0155340
   PubMedGoogle Scholar
• Von Heijne G. The signal peptide. J Membrane Biol 1990; 115:195-201; http://dx.doi.org/10.1007/BF01868635
   PubMed Web of Science ®Google Scholar
• Toubart P, Desiderio A, Salvi G, Cervone F, Daroda L, De Lorenzo G, Bergmann C, Darvill AG, Albersheim P. Cloning and characterization of the gene encoding the endopolygalacturonase-inhibiting protein (PGIP) of Phaseoulus vulgaris L. Plant J 1992; 2:367-73; PMID:1303801
   PubMed Web of Science ®Google Scholar
• Kirnbauer Schellenbacher C, Roden R, Kirnbauer R. Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines. J Virol 2009; 83:10085-95; PMID:19640991; http://dx.doi.org/10.1128/JVI.01088-09
   PubMed Web of Science ®Google Scholar
• Miyahira Y, Murata K, Rodriguez D, Rodriguez JR, Esteban M, Rodrigues MM, Zavala F. Quantification of antigen specific CD8+ T cells using an ELISPOT assay. J Immunol Methods 1995; 181:45-54; PMID:7537312; http://dx.doi.org/10.1016/0022-1759(94)00327-S
   PubMed Web of Science ®Google Scholar
• Hsu KF, Hung CF, Cheng WF, He L, Slater LA, Ling M, Wu TC. Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen. Gene Ther 2001; 8:376-83; PMID:11313814; http://dx.doi.org/10.1038/sj.gt.3301408
   PubMed Web of Science ®Google Scholar